Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000052

Director sold 797 shares at an average $20.92 ($16,670)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Greenleaf Peter · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-02 Sale : show line 1 in the form 10b5-1 −420 $20.52 $8,616 25,058 D
2026-04-02 Sale : show line 2 in the form 10b5-1 −377 $21.36 $8,053 24,681 D
Open-market sales · 797 sh · avg $20.92 · $16,670
Loading xslF345X06/wk-form4_1775509257.xml…